Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 5/20 | 0.53 |
| ▸ | BTK | Q06187 | 2/20 | 0.53 |
| ▸ | PTK2 | Q05397 | 12/20 | 0.49 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.43 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | IRAK3 | Q9Y616 | 1/20 | 0.43 |
| ▸ | ITK | Q08881 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31595461 | 1.00 | CRBN (0.53) | CRBNBTKPTK2ARALK | |
| SCHEMBL23267675 | 0.85 | PTK2 (0.49) | CRBNBTKPTK2AR | |
| SCHEMBL31595777 | 0.84 | CRBN (0.53) | CRBNBTKPTK2ARALK | |
| SCHEMBL23268167 | 0.84 | PTK2 (0.49) | CRBNBTKPTK2AR | |
| SCHEMBL23249916 | 0.83 | BCL6 (0.57) | CRBNBTKPTK2ARALK | |
| SCHEMBL29874253 | 0.83 | BCL6 (0.57) | CRBNBTKPTK2ARALK | |
| SCHEMBL23249960 | 0.83 | BCL6 (0.57) | CRBNBTKPTK2ARALK | |
| SCHEMBL29874152 | 0.83 | BCL6 (0.57) | CRBNBTKPTK2ARALK | |
| SCHEMBL31595205 | 0.83 | PTK2 (0.50) | CRBNBTKPTK2AR | |
| SCHEMBL23267394 | 0.83 | PTK2 (0.50) | CRBNBTKPTK2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021077010-A1 | BIFUNCTIONAL MOLECULES CONTAINING AN E3 UBIQUITINE LIGASE BINDING MOIETY LINKED TO A BCL6 TARGETING MOIETY | ARVINAS OPERATIONS, INC. (US) | 2021-04-22 | — | — | WO | disclosed |